Oakworth Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.9K | Sell |
683
-526
| -44% | -$42.4K | ﹤0.01% | 458 |
|
|
2026
Q1 | $105K | Sell |
1,209
-146
| -11% | -$14K | 0.01% | 354 |
|
|
2025
Q4 | $130K | Buy |
1,355
+153
| +13% | +$14.9K | 0.01% | 305 |
|
|
2025
Q3 | $114K | Buy |
1,202
+300
| +33% | +$27.6K | 0.01% | 325 |
|
|
2025
Q2 | $78.6K | Sell |
902
-241
| -21% | -$20.4K | 0.01% | 317 |
|
|
2025
Q1 | $103K | Hold |
1,143
| – | – | 0.01% | 292 |
|
|
2024
Q4 | $91.3K | Hold |
1,143
| – | – | 0.01% | 296 |
|
|
2024
Q3 | $103K | Sell |
1,143
-52
| -4% | -$4.37K | 0.01% | 276 |
|
|
2024
Q2 | $94.1K | Sell |
1,195
-729
| -38% | -$59.8K | 0.01% | 275 |
|
|
2024
Q1 | $168K | Buy |
1,924
+468
| +32% | +$39.9K | 0.01% | 210 |
|
|
2023
Q4 | $120K | Buy |
1,456
+101
| +7% | +$7.7K | 0.01% | 229 |
|
|
2023
Q3 | $106K | Sell |
1,355
-487
| -26% | -$40.8K | 0.01% | 225 |
|
|
2023
Q2 | $162K | Buy |
1,842
+96
| +5% | +$8.27K | 0.01% | 193 |
|
|
2023
Q1 | $141K | Sell |
1,746
-1,855
| -52% | -$151K | 0.01% | 202 |
|
|
2022
Q4 | $280K | Buy |
3,601
+69
| +2% | +$5.59K | 0.03% | 131 |
|
|
2022
Q3 | $286K | Sell |
3,532
-100
| -3% | -$8.99K | 0.03% | 134 |
|
|
2022
Q2 | $326K | Sell |
3,632
-1,626
| -31% | -$165K | 0.03% | 131 |
|
|
2022
Q1 | $584K | Sell |
5,258
-269
| -5% | -$28.4K | 0.05% | 100 |
|
|
2021
Q4 | $572K | Sell |
5,527
-388
| -7% | -$44.9K | 0.05% | 99 |
|
|
2021
Q3 | $741K | Buy |
5,915
+700
| +13% | +$90.6K | 0.07% | 81 |
|
|
2021
Q2 | $647K | Buy |
5,215
+102
| +2% | +$12.8K | 0.06% | 92 |
|
|
2021
Q1 | $604K | Buy |
5,113
+14
| +0.3% | +$1.64K | 0.07% | 89 |
|
|
2020
Q4 | $597K | Sell |
5,099
-95
| -2% | -$10.5K | 0.08% | 85 |
|
|
2020
Q3 | $540K | Buy |
5,194
+57
| +1% | +$5.72K | 0.09% | 80 |
|
|
2020
Q2 | $471K | Buy |
5,137
+1,990
| +63% | +$191K | 0.08% | 86 |
|
|
2020
Q1 | $284K | Buy |
3,147
+1,285
| +69% | +$137K | 0.07% | 107 |
|
|
2019
Q4 | $217K | Buy |
1,862
+1,184
| +175% | +$130K | 0.04% | 153 |
|
|
2019
Q3 | $74K | Sell |
678
-2,314
| -77% | -$241K | 0.01% | 249 |
|
|
2019
Q2 | $291K | Buy |
2,992
+205
| +7% | +$18.7K | 0.06% | 129 |
|
|
2019
Q1 | $254K | Hold |
2,787
| – | – | 0.05% | 142 |
|
|
2018
Q4 | $253K | Hold |
2,787
| – | – | 0.06% | 134 |
|
|
2018
Q3 | $274K | Hold |
2,787
| – | – | 0.05% | 142 |
|
|
2018
Q2 | $238K | Hold |
2,787
| – | – | 0.05% | 145 |
|
|
2018
Q1 | $224K | Sell |
2,787
-15
| -0.5% | -$1.24K | 0.05% | 144 |
|
|
2017
Q4 | $230K | Sell |
2,802
-100
| -3% | -$8.01K | 0.05% | 143 |
|
|
2017
Q3 | $234K | Hold |
2,902
| – | – | 0.06% | 142 |
|
|
2017
Q2 | $258K | Sell |
2,902
-485
| -14% | -$40.9K | 0.07% | 129 |
|
|
2017
Q1 | $273K | Sell |
3,387
-128
| -4% | -$10K | 0.08% | 120 |
|
|
2016
Q4 | $257K | Buy |
3,515
+105
| +3% | +$8.25K | 0.08% | 127 |
|
|
2016
Q3 | $295K | Sell |
3,410
-70
| -2% | -$6.1K | 0.1% | 104 |
|
|
2016
Q2 | $280K | Buy |
3,480
+2,092
| +151% | +$169K | 0.1% | 107 |
|
|
2016
Q1 | $104K | Buy |
1,388
+700
| +102% | +$52.7K | 0.04% | 164 |
|
|
2015
Q4 | $53K | Buy |
688
+545
| +381% | +$41K | 0.02% | 186 |
|
|
2015
Q3 | $10K | Hold |
143
| – | – | 0.01% | 296 |
|
|
2015
Q2 | $11K | Hold |
143
| – | – | 0.01% | 294 |
|
|
2015
Q1 | $11K | Buy |
+143
| New | +$10.8K | 0.01% | 309 |
|
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
VF
Oakworth Capital's MDT Position: Q2 2026 in Review
Oakworth Capital reduced its Medtronic (MDT) stake by 44% in Q2 2026, selling an estimated $42.4K and leaving 683 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #458.
Oakworth Capital first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $741K in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Oakworth Capital held 683 shares of Medtronic worth $53.9K as of Q2 2026.
- Oakworth Capital sold 526 Medtronic shares in Q2 2026, an estimated $42.4K.
- Medtronic made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #458 holding.
- Oakworth Capital first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
- Oakworth Capital's Medtronic position peaked at $741K in Q3 2021.
- 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.